Current Therapeutic Options for Heart Failure in Elderly Patients
نویسندگان
چکیده
منابع مشابه
Current Therapeutic Options for Heart Failure in Elderly Patients
Heart failure (HF) is a major and growing public health problem with high morbidity and mortality (Ponikowski et al., 2016). It affects 1-2% of the general population in developed countries, and the average age at diagnosis is 76 years. Because of a better management of acute phase and comorbidities, HF incidence is increasing in elderly patients, with a prevalence rising to 10% among people ag...
متن کاملHeart Failure: Update on Therapeutic Options
Heart failure statistics are daunting: 550,000 new cases each year, a 1-year mortality rate of nearly 20%, and annual direct and indirect costs that total $24.3 billion.1 The diverse etiology of heart failure and the complex, progressive course of the disease can make treatment decisions daunting as well. Here I discuss current recommendations for heart failure management, as well as the clinic...
متن کاملNew therapeutic options in congestive heart failure: Part I.
New Therapeutic Options in Congestive Heart Failure: Part I Print ISSN: 0009-7322. Online ISSN: 1524-4539 Copyright © 2002 American Heart Association, Inc. All rights reserved. is published by the American Heart Association, 7272 Greenville Avenue, Dallas, TX 75231 Circulation doi: 10.1161/01.CIR.0000014763.63528.9D 2002;105:2099-2106 Circulation. http://circ.ahajournals.org/content/105/17/2099...
متن کاملNew therapeutic options in congestive heart failure: Part II.
Anticytokine and Immunomodulating Therapy Cytokines, such as tumor necrosis factor, are produced in increased amounts in a variety of tissues in patients with CHF.1 Higher plasma cytokine concentrations are associated with a worse prognosis.1 Experimentally, cytokines depress myocardial contractility, cause myocyte death, and induce heart failure.1 There is some evidence that anticytokine inter...
متن کاملCurrent therapeutic options in psoriasis
Introduction Psoriasis is a chronic skin disorder, characterized by inflammatory and hyperproliferative processes. Globally, reports on the prevalence of psoriasis reveal major differences in terms of ethnicity and climate zone, ranging between 0 and 11.8% (Jacobson et al 2011). In Europe, psoriasis affects approximately 2-3% of the population. Psoriasis onset can occur at any age, including bi...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: BioMed Research International
سال: 2017
ISSN: 2314-6133,2314-6141
DOI: 10.1155/2017/1483873